Literature DB >> 8463463

Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: An open trial.

D Eisen1.   

Abstract

BACKGROUND: Oral lichen planus is chronic and can be debilitating. Topical corticosteroids are most frequently used for treatment, but they are not always effective.
OBJECTIVE: Hydroxychloroquine sulfate (Plaquenil), an antimalarial agent, was evaluated in an open trial (10 patients) for its ability to improve oral lichen planus.
METHODS: Patients received hydroxychloroquine, 200 to 400 mg daily, as a monotherapy for 6 months. Patients were assessed at baseline and every 4 to 8 weeks during treatment. Baseline ophthalmologic examinations were performed, and laboratory values were monitored before and during treatment.
RESULTS: Nine of ten patients had an excellent response to therapy. Three of six patients with erosions at baseline had complete healing. Pain relief and reduced erythema were usually observed after 1 to 2 months of therapy, but erosions required 3 to 6 months of treatment before they resolved. There were no adverse effects.
CONCLUSION: Hydroxychloroquine may be useful in the treatment of oral lichen planus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463463     DOI: 10.1016/0190-9622(93)70082-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Purplish, pruritic papules on the limbs.

Authors:  J C Cather; M A Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-10

2.  [Translated article] Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19.

Authors:  D Morgado-Carrasco; J Ibaceta-Ayala; J Piquero-Casals
Journal:  Actas Dermosifiliogr       Date:  2022-02

3.  Hydroxychloroquine decreases the upregulated frequencies of Tregs in patients with oral lichen planus.

Authors:  Yanan Zhu; Jingjing Li; Yang Bai; Xiang Wang; Ning Duan; Hongliu Jiang; Tingting Wang; Wenmei Wang
Journal:  Clin Oral Investig       Date:  2014-01-14       Impact factor: 3.573

Review 4.  Oral lichenoid lesions - a review and update.

Authors:  Venkatesh Vishwanath Kamath; Krishnanand Setlur; Komali Yerlagudda
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

5.  Oral and vulvo-vaginal lichenoid reactions due to mitotane (Lysodren): A case report.

Authors:  Arthur Schmouchkovitch; Héloïse Herry; Philippe Thuillier; Véronique Kerlan; Camille Fleuret; Guy Le Toux; Sylvie Boisramé
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

Review 6.  Hydroxychloroquine: from malaria to autoimmunity.

Authors:  Ilan Ben-Zvi; Shaye Kivity; Pnina Langevitz; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 7.  Therapeutic strategies for oral lichen planus: State of the art and new insights.

Authors:  Dario Didona; Raffaele Dante Caposiena Caro; Antonio Manuel Sequeira Santos; Farzan Solimani; Michael Hertl
Journal:  Front Med (Lausanne)       Date:  2022-10-04

8.  Dermatology for the allergist.

Authors:  Dennis Kim; Richard Lockey
Journal:  World Allergy Organ J       Date:  2010-06-15       Impact factor: 4.084

Review 9.  New concepts in antimalarial use and mode of action in dermatology.

Authors:  Sunil Kalia; Jan P Dutz
Journal:  Dermatol Ther       Date:  2007 Jul-Aug       Impact factor: 2.851

10.  [Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].

Authors:  D Morgado-Carrasco; J Ibaceta-Ayala; J Piquero-Casals
Journal:  Actas Dermosifiliogr       Date:  2021-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.